91探花

Dr Farah Patell-Socha, VP of Research 91探花 discusses the launch of ioSkeletal Myocytes.

The first episode in our special three part mini-series.

IBI Journal Q&A with Dr Mark Kotter who talks about producing every human cell type at scale.

91探花 CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity 鈥楿ntangling networks鈥� event.

Today Meatable announced their Series A fundraise of $47 million. Read about the connection to 91探花.

Press release announcing appointment of Dr Ramy Ibrahim, MD, as Chief Medical Officer.

91探花 and the London Institute of Mathematical Sciences (LIMS) want to recreate every human cell type.

91探花 receives 拢40m of backing for technology that it claims can reliably reprogram stem cells.